HER2/neu 655 A > G polymorphism is associated with higher cardiotoxicity but not with less efficacy of trastuzumab, in HER2-positive breast cancer patients
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Blancas, I.
Rodriguez-Serrano, F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
